Our federal and state governments have dragged their feet in addressing the risks of BPA exposure - due mainly to relentless lobbying by the chemical industry. The chemical industry has used every weapon at its disposal - including lawsuits, in the case of San Francisco - to keep BPA on the shelves and in our bodies. So the Food and Drug Administration deserves mild applause for reversing its position on BPA, calling it a concern" and offering ways in which the public can reduce its exposure to the chemical. It would have been far better for the FDA to ban the chemical, or at least require manufacturers to label products that contain it. Instead, it offered the familiar "more study is needed" defense and said that it doesn't have enough data to support a legal crackdown.